2024-07-012025-06-302025-06-30false10890538NEWAFRICA BIOENERGY LIMITED2026-07-02falseiso4217:GBPxbrli:pure108905382024-06-30108905382025-06-30108905382024-07-012025-06-30108905382023-06-30108905382024-06-30108905382023-07-012024-06-3010890538bus:SmallEntities2024-07-012025-06-3010890538bus:AuditExempt-NoAccountantsReport2024-07-012025-06-3010890538bus:FullAccounts2024-07-012025-06-3010890538bus:PrivateLimitedCompanyLtd2024-07-012025-06-3010890538core:WithinOneYear2025-06-3010890538core:AfterOneYear2025-06-3010890538core:WithinOneYear2024-06-3010890538core:AfterOneYear2024-06-3010890538core:ShareCapital2025-06-3010890538core:SharePremium2025-06-3010890538core:RevaluationReserve2025-06-3010890538core:OtherReservesSubtotal2025-06-3010890538core:RetainedEarningsAccumulatedLosses2025-06-3010890538core:ShareCapital2024-06-3010890538core:SharePremium2024-06-3010890538core:RevaluationReserve2024-06-3010890538core:OtherReservesSubtotal2024-06-3010890538core:RetainedEarningsAccumulatedLosses2024-06-3010890538core:LandBuildings2025-06-3010890538core:PlantMachinery2025-06-3010890538core:Vehicles2025-06-3010890538core:FurnitureFittings2025-06-3010890538core:OfficeEquipment2025-06-3010890538core:NetGoodwill2025-06-3010890538core:IntangibleAssetsOtherThanGoodwill2025-06-3010890538core:ListedExchangeTraded2025-06-3010890538core:UnlistedNon-exchangeTraded2025-06-3010890538core:LandBuildings2024-06-3010890538core:PlantMachinery2024-06-3010890538core:Vehicles2024-06-3010890538core:FurnitureFittings2024-06-3010890538core:OfficeEquipment2024-06-3010890538core:NetGoodwill2024-06-3010890538core:IntangibleAssetsOtherThanGoodwill2024-06-3010890538core:ListedExchangeTraded2024-06-3010890538core:UnlistedNon-exchangeTraded2024-06-3010890538core:LandBuildings2024-07-012025-06-3010890538core:PlantMachinery2024-07-012025-06-3010890538core:Vehicles2024-07-012025-06-3010890538core:FurnitureFittings2024-07-012025-06-3010890538core:OfficeEquipment2024-07-012025-06-3010890538core:NetGoodwill2024-07-012025-06-3010890538core:IntangibleAssetsOtherThanGoodwill2024-07-012025-06-3010890538core:ListedExchangeTraded2024-07-012025-06-3010890538core:UnlistedNon-exchangeTraded2024-07-012025-06-3010890538core:MoreThanFiveYears2024-07-012025-06-3010890538core:Non-currentFinancialInstruments2025-06-3010890538core:Non-currentFinancialInstruments2024-06-3010890538dpl:CostSales2024-07-012025-06-3010890538dpl:DistributionCosts2024-07-012025-06-3010890538core:LandBuildings2024-07-012025-06-3010890538core:PlantMachinery2024-07-012025-06-3010890538core:Vehicles2024-07-012025-06-3010890538core:FurnitureFittings2024-07-012025-06-3010890538core:OfficeEquipment2024-07-012025-06-3010890538dpl:AdministrativeExpenses2024-07-012025-06-3010890538core:NetGoodwill2024-07-012025-06-3010890538core:IntangibleAssetsOtherThanGoodwill2024-07-012025-06-3010890538dpl:GroupUndertakings2024-07-012025-06-3010890538dpl:ParticipatingInterests2024-07-012025-06-3010890538dpl:GroupUndertakingscore:ListedExchangeTraded2024-07-012025-06-3010890538core:ListedExchangeTraded2024-07-012025-06-3010890538dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-07-012025-06-3010890538core:UnlistedNon-exchangeTraded2024-07-012025-06-3010890538dpl:CostSales2023-07-012024-06-3010890538dpl:DistributionCosts2023-07-012024-06-3010890538core:LandBuildings2023-07-012024-06-3010890538core:PlantMachinery2023-07-012024-06-3010890538core:Vehicles2023-07-012024-06-3010890538core:FurnitureFittings2023-07-012024-06-3010890538core:OfficeEquipment2023-07-012024-06-3010890538dpl:AdministrativeExpenses2023-07-012024-06-3010890538core:NetGoodwill2023-07-012024-06-3010890538core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3010890538dpl:GroupUndertakings2023-07-012024-06-3010890538dpl:ParticipatingInterests2023-07-012024-06-3010890538dpl:GroupUndertakingscore:ListedExchangeTraded2023-07-012024-06-3010890538core:ListedExchangeTraded2023-07-012024-06-3010890538dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-07-012024-06-3010890538core:UnlistedNon-exchangeTraded2023-07-012024-06-3010890538core:NetGoodwill2025-06-3010890538core:IntangibleAssetsOtherThanGoodwill2025-06-3010890538core:LandBuildings2025-06-3010890538core:PlantMachinery2025-06-3010890538core:Vehicles2025-06-3010890538core:FurnitureFittings2025-06-3010890538core:OfficeEquipment2025-06-3010890538core:AfterOneYear2025-06-3010890538core:WithinOneYear2025-06-3010890538core:ListedExchangeTraded2025-06-3010890538core:UnlistedNon-exchangeTraded2025-06-3010890538core:ShareCapital2025-06-3010890538core:SharePremium2025-06-3010890538core:RevaluationReserve2025-06-3010890538core:OtherReservesSubtotal2025-06-3010890538core:RetainedEarningsAccumulatedLosses2025-06-3010890538core:NetGoodwill2024-06-3010890538core:IntangibleAssetsOtherThanGoodwill2024-06-3010890538core:LandBuildings2024-06-3010890538core:PlantMachinery2024-06-3010890538core:Vehicles2024-06-3010890538core:FurnitureFittings2024-06-3010890538core:OfficeEquipment2024-06-3010890538core:AfterOneYear2024-06-3010890538core:WithinOneYear2024-06-3010890538core:ListedExchangeTraded2024-06-3010890538core:UnlistedNon-exchangeTraded2024-06-3010890538core:ShareCapital2024-06-3010890538core:SharePremium2024-06-3010890538core:RevaluationReserve2024-06-3010890538core:OtherReservesSubtotal2024-06-3010890538core:RetainedEarningsAccumulatedLosses2024-06-3010890538core:NetGoodwill2023-06-3010890538core:IntangibleAssetsOtherThanGoodwill2023-06-3010890538core:LandBuildings2023-06-3010890538core:PlantMachinery2023-06-3010890538core:Vehicles2023-06-3010890538core:FurnitureFittings2023-06-3010890538core:OfficeEquipment2023-06-3010890538core:AfterOneYear2023-06-3010890538core:WithinOneYear2023-06-3010890538core:ListedExchangeTraded2023-06-3010890538core:UnlistedNon-exchangeTraded2023-06-3010890538core:ShareCapital2023-06-3010890538core:SharePremium2023-06-3010890538core:RevaluationReserve2023-06-3010890538core:OtherReservesSubtotal2023-06-3010890538core:RetainedEarningsAccumulatedLosses2023-06-3010890538core:AfterOneYear2024-07-012025-06-3010890538core:WithinOneYear2024-07-012025-06-3010890538core:Non-currentFinancialInstrumentscore:CostValuation2024-07-012025-06-3010890538core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-07-012025-06-3010890538core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-07-012025-06-3010890538core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-07-012025-06-3010890538core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-07-012025-06-3010890538core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-07-012025-06-3010890538core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-07-012025-06-3010890538core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-07-012025-06-3010890538core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-07-012025-06-3010890538core:Non-currentFinancialInstrumentscore:CostValuation2025-06-3010890538core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-06-3010890538core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-06-3010890538core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-06-3010890538core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-06-3010890538core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-06-3010890538core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-06-3010890538core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-06-3010890538core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-06-3010890538core:Non-currentFinancialInstrumentscore:CostValuation2024-06-3010890538core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-3010890538core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-3010890538core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-3010890538core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-3010890538core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-3010890538core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-3010890538core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-3010890538core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-3010890538bus:Director12024-07-012025-06-3010890538bus:Director22024-07-012025-06-3010890538bus:Director32024-07-012025-06-30

NEWAFRICA BIOENERGY LIMITED

Registered Number
10890538
(England and Wales)

Unaudited Financial Statements for the Year ended
30 June 2025

NEWAFRICA BIOENERGY LIMITED
Company Information
for the year from 1 July 2024 to 30 June 2025

Directors

ASPREM, Mads Michael
ERIKSSON, Bo Sören
LOVHAUGEN, Odd Ivar

Registered Address

47 Topsfield Parade Tottenham Lane
London
N8 8PT

Registered Number

10890538 (England and Wales)
NEWAFRICA BIOENERGY LIMITED
Balance Sheet as at
30 June 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets41,7342,167
Investments5674,284930,123
676,018932,290
Current assets
Debtors167,504(79,461)
Cash at bank and on hand4539
167,957(79,452)
Creditors amounts falling due within one year6(38,906)(25,375)
Net current assets (liabilities)129,051(104,827)
Total assets less current liabilities805,069827,463
Creditors amounts falling due after one year7(292,462)(297,722)
Net assets512,607529,741
Capital and reserves
Called up share capital420,654262,119
Share premium707,935707,935
Profit and loss account(615,982)(440,313)
Shareholders' funds512,607529,741
The financial statements were approved and authorised for issue by the Board of Directors on 2 July 2026, and are signed on its behalf by:
ERIKSSON, Bo Sören
Director
Registered Company No. 10890538
NEWAFRICA BIOENERGY LIMITED
Notes to the Financial Statements
for the year ended 30 June 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the company information page. Company details: NEWAFRICA BIOENERGY LIMITED The registered office is 47 Topsfield Parade, Tottenham Lane, London, N8 8PT. Office Address: 34B York Way, London, N1 9AB, United Kingdom Email: contact@newafrica.com Website: www.newafricabioenergy.com
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Office Equipment20
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
2.Average number of employees

20252024
Average number of employees during the year12
3.Further information regarding the company's income
NAB have made big efforts in finding and developing new projects and made full proposals for two projects of which NAB has been elected developer and for the second NAB has been shortlisted. With reference to earlier developed projects have three of them been postponed. NAB continued to work with the leading forest owners and wood processors in the countries where it operates, provide new solutions for the biomass supply chain and their energy supply. All projects will provide significant amounts of energy for rural communities.
4.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 July 245,2545,254
At 30 June 255,2545,254
Depreciation and impairment
At 01 July 243,0873,087
Charge for year433433
At 30 June 253,5203,520
Net book value
At 30 June 251,7341,734
At 30 June 242,1672,167
5.Fixed asset investments

Other investments1

Total

££
Cost or valuation
At 01 July 24930,123930,123
Disposals(255,839)(255,839)
At 30 June 25674,284674,284
Net book value
At 30 June 25674,284674,284
At 30 June 24930,123930,123

Notes

1Other investments other than loans
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables4,1644,351
Bank borrowings and overdrafts3,4233,473
Taxation and social security7,8294,744
Other creditors2,7083,941
Accrued liabilities and deferred income20,7828,866
Total38,90625,375
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method. Accounts Payable 2,185 Other Creditors 1,979 PAYE 5,863 Bank Loans and overdrafts - Current Portion 3,423 Foreign Tax Payable 1,966 Director's Loan - Short term (5,039) Accruals 20,782 Other creditors 2,708 ________ TOTAL CREDITORS WITHIN ONE YEAR £ 33,867
7.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts107,104106,412
Other creditors185,358191,310
Total292,462297,722
Long Term Bank Loan 3,454 Lux Bank Loan Account 103,650 Loan - SCAF 185,358 ________ TOTAL CREDITORS AFTER ONE YEAR £292,462